Progress in Head and Neck Cancer Immunotherapy: Can Tolerance and Immune Suppression Be Reversed?

Publisher： Karger

E-ISSN： 1423-0275|66|6|332-340

ISSN： 0301-1569

Source： ORL, Vol.66, Iss.6, 2005-01, pp. : 332-340

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Checkpoint Inhibition in Head and Neck Cancer: Immune Therapeutic Options, Limitations, and Beyond

ORL, Vol. 79, Iss. 1-2, 2017-02 ,pp. : 24-33

Karger

Access to resources Recommend Favorite

Quality of Life in Head and Neck Cancer

By Ferlito Alfio Rogers Simon N. Shaha Ashok R. Bradley Patrick J. Rinaldo Alessandra

Acta Oto-Laryngologica, Vol. 123, Iss. 1, 2003-01 ,pp. : 8-13

Informa Healthcare

Access to resources Recommend Favorite

Electroporation Therapy in Head and Neck Cancer

By Burian Martin Formanek Michael Regele Heinz

Acta Oto-Laryngologica, Vol. 123, Iss. 2, 2003-01 ,pp. : 264-268

Informa Healthcare

Access to resources Recommend Favorite

Outcomes Research in Head and Neck Cancer

ORL, Vol. 66, Iss. 4, 2004-10 ,pp. : 207-213

Karger

Access to resources Recommend Favorite

Tumor-associated Antigens as Possible Targets for Immune Therapy in Head and Neck Cancer: Comparative mRNA Expression Analysis of RAGE and GAGE Genes

By Götte Karl Usener Dirk Riedel Frank Hörmann Karl Schadendorf Dirk Eichmüller Stefan

Acta Oto-Laryngologica, Vol. 122, Iss. 5, 2002-07 ,pp. : 546-552

Informa Healthcare

Access to resources Recommend Favorite